Evidence-based assessment/Vignettes/Jay
HGAPS is finding new ways to make psychological science conferences more accessible!
Here are examples from APA 2022 and the JCCAP Future Directions Forum. Coming soon... ABCT!
~ More at HGAPS.org ~
Jay edit
Clinical description edit
Jay is a 22-year-old male undergraduate student at the University of North Carolina at Chapel Hill (UNC). Jay was previously diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). In college, Jay complained of having difficulties with sustaining attention, reading, inadequate study habits, and poor performance in his college courses (relative to his high school performance). He has been experiencing mood fluctuations. Jay has been feeling anxious for a long time. He says that he has "panic attacks" and "persistent worrying."
History of presenting a problem edit
Jay had previously been evaluated for Attention-Deficit/Hyperactivity Disorder (ADHD) and was diagnosed. In addition to attention and reading difficulties, Jay reported clinically significant disordered mood and fluctuations in mood (i.e., periods of “highs” and “lows”), and a strong family history of bipolar disorder. Finally, Jay reported a longstanding history of anxiety, including panic attacks and persistent worrying.
Conceptualization edit
Initial treatment plan edit
Assessment Findings edit
Checklist Scores edit
Extended content
|
---|
Select more specialized scales to refine probabilities editUpdating probabilities editCritical items edit |
Diagnostic Interview findings edit
Cognitive and Achievement Testing edit
(Not done as part of the evaluation; may be able to match up information later)
Prediction Phase edit
Let's see how we would apply the EBA principles to Arlene:
Shortlist of Probable Hypotheses edit
Based on Jay's age and the common clinical issues, here are the possible issues:
- Attention problems
- Anxiety disorders
- Substance misuse should be another hypothesis, based again on its prevalence in his age group.
- A mood disorder
Risk and Protective Factors and Moderators edit
Updating Probability of Diagnoses edit
Could add table with DLRS and revised probabilities, or leave them blank and have a "key" section?
Jay | Common Dx Hypotheses (A) | Starting Prob. (B) | Broad Measure (D) | Cross-informant (E) | Confirmation (G) | Treatment Phase (I), (J), (K) | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Base Rate from Kessler et al. (2005) NCS-R | Scale & Score | DLR | Revised Prob. | EAY Check | Next Test score | DLR | Revised Prob. | MINI | |||
Specific Phobia | 0.13 | ||||||||||
PTSD | 0.06 | ||||||||||
GAD | 0.04 | Generalized Anxiety Disorder Current | |||||||||
Panic Disorder | 0.04 | Panic Disorder Lifetime | |||||||||
Social Phobia | 0.14 | ||||||||||
Separation Anxiety | 0.02 | ||||||||||
Any Impulse Control Disorder | ODD | 0.10 | |||||||||
CD | 0.11 | ||||||||||
ADHD | 0.08 | Adult ADHD | |||||||||
Any Mood Disorder | MDD | 0.15 | BDI | Major Depressive Episode w/ Melancholic Features, Past | |||||||
BP | 0.06 | MDQ | KSADS Mania Scale? | Hypomanic Episode | |||||||
Dysthymia | 0.02 | ||||||||||
Any Substance Abuse Disorder | 0.17 |
Answers | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cross Informant Perspectives edit
Mention that these have DLRs. Also unpack the implications of agreement and disagreement for the client (and add a section about treatment implications of disagreement on the Conceptual Model Pages)
Prescription Phase edit
Mental Status and Clinical Observations edit
add content
Treatment Selection edit
Moderating Factors edit
Client Preferences edit
Process Phase edit
Clinically Significant Change edit
Reliable Change Index edit
Pick a treatment target and specify what the RCI would be for it. Discuss how you would explain to Arlene
Nomothetic Benchmarks edit
A, B, Cs of Jacobson definitions. General stuff about limitations would go on the main concept page. Here it is focused on the client -- what are the benchmarks they will focus on? How explained to them?
Interpreting benchmarks edit
Minimum Important Difference (MID) edit
Note that this section is a dangler -- not originally called out in the 12 steps. Medium d as a rule of thumb from Streiner, Norman, & Cairney (2015). Could work from AUC to d to raw units as a way of estimating, since psychology hasn't done research on this yet. Might be able to back into it with studies that had CSQ and outcome data.
Client Goals & Tracking edit
These would be personal goals and idiographic measurement -- YTOPS, etc.
Process Measures edit
This would be traces such as coming to sessions, doing homework assignments. (Not sure of other specifics involved in current IPT protocols?)
Progress Measures edit
YTOPS again and goal setting.
Termination Planning and Maintenance edit
Revisit Jacobson benchmarks. Is there much chance of relapse? What things would the client need to pay attention to if they were going to nip that in the bud?
- ↑ Merikangas, Kathleen Ries; He, Jian-ping; Burstein, Marcy; Swanson, Sonja A.; Avenevoli, Shelli; Cui, Lihong; Benjet, Corina; Georgiades, Katholiki et al.. "Lifetime Prevalence of Mental Disorders in U.S. Adolescents: Results from the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A)". Journal of the American Academy of Child & Adolescent Psychiatry 49 (10): 980–989. doi:10.1016/j.jaac.2010.05.017. PMID 20855043. PMC PMC2946114. https://dx.doi.org/10.1016/j.jaac.2010.05.017.